Showing Form 4 filings for DGX
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
DGX
Price
$242.72
Shares
10,000
Ownership
122,423
Value/Share
Davis J. E.
CEO, Pres
Unknown
Industry
$235.18
1,600
10,335
Delaney Mark E
SVP, Chief Commercial Officer
$194.14
132,423
$206.21
5,558
71,624
Doherty Catherine T.
EVP, Regional Businesses
3,878
43,294
Prevoznik Michael E
SVP, GC
2,855
15,198
Plewman Patrick
SVP for Diagnostic Services
$204.86
2,628
15,457
Kuppusamy Karthik
SVP, Clinical Solutions
$207.73
632
526
$212.52
117,185
410
$191.76
1,250
17,037
Gregg Vicky B
Dir
$185.00
1,975
15,269
$180.00
17,244
$175.52
1,748
7,498
$175.51
$168.46
39,191
127,623
$170.00
2,555
12,546
4,643
43,758
$174.13
5,370
72,495
$175.79
716
77,865
592
48,400
$172.61
528
44,672
824
73,606
$170.99
604
45,486
$169.71
320
18,082
$170.51
1,434
74,885
$164.57
16,867
$164.30
403
4,624
$156.92
1,775
11,656